Vanguard reports zero stake in Cognex (NASDAQ: CGNX) after realignment
Rhea-AI Filing Summary
The Vanguard Group files an amendment stating it holds 0 shares (0%) of Cognex Corp common stock. The filing notes an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries to report holdings separately. The statement is signed by Ashley Grim, Head of Global Fund Administration on 03/26/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial ownership after internal reorganization.
The filing shows 0 shares (0%) beneficially owned of Cognex common stock and explains a January 12, 2026 internal realignment that led to disaggregated reporting by Vanguard subsidiaries. This is an administrative disclosure reflecting reporting structure rather than trading activity.
Cash‑flow treatment and any subsidiary holdings are not detailed in the excerpt; subsequent filings from the named subsidiaries may show beneficial positions if applicable.
FAQ
Does The Vanguard Group currently own any Cognex (CGNX) shares?
Why does Vanguard say subsidiaries will report separately for CGNX?
Who signed the Schedule 13G/A for Vanguard regarding Cognex?
Does this filing indicate any purchases or sales of CGNX by Vanguard?
Will this Schedule 13G/A affect Cognex shareholder voting outcomes?